A phase IIb trial of vorinostat in combination with lenalidomide and dexamethasone in patients with multiple myeloma refractory to previous lenalidomide-containing regimens.
about
Novel Proteasome Inhibitors and Histone Deacetylase Inhibitors: Progress in Myeloma Therapeutics.Safety and efficacy of vorinostat, bortezomib, doxorubicin and dexamethasone in a phase I/II study for relapsed or refractory multiple myeloma (VERUMM study: vorinostat in elderly, relapsed and unfit multiple myeloma)
P2860
A phase IIb trial of vorinostat in combination with lenalidomide and dexamethasone in patients with multiple myeloma refractory to previous lenalidomide-containing regimens.
description
2016 nî lūn-bûn
@nan
2016 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
A phase IIb trial of vorinosta ...... alidomide-containing regimens.
@ast
A phase IIb trial of vorinosta ...... alidomide-containing regimens.
@en
type
label
A phase IIb trial of vorinosta ...... alidomide-containing regimens.
@ast
A phase IIb trial of vorinosta ...... alidomide-containing regimens.
@en
prefLabel
A phase IIb trial of vorinosta ...... alidomide-containing regimens.
@ast
A phase IIb trial of vorinosta ...... alidomide-containing regimens.
@en
P2093
P2860
P356
P1476
A phase IIb trial of vorinosta ...... alidomide-containing regimens.
@en
P2093
David H Vesole
David S Siegel
Elizabeth Bilotti
Joshua R Richter
Kristin Ivanovski
Larysa Sanchez
Laura McBride
Palka Anand
P2860
P304
P356
10.1111/BJH.14429
P407
P577
2016-11-18T00:00:00Z